...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Share transfer RBC
1
May 01, 2019 10:56PM
1
May 02, 2019 08:21AM
2
May 02, 2019 10:40AM

The new Managements estimate of fair value of common share is out on the Zenith website, letter is dated May 5, 2019 for a valuation of .725USD per share(.98CAD) as of Jan 31, 2019 


May 03, 2019 07:49AM
1
May 03, 2019 08:46AM
2
May 03, 2019 10:17AM
1
May 03, 2019 11:50AM
2
May 03, 2019 01:33PM
Share
New Message
Please login to post a reply